Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
New health mapping study pinpoints cancer risk factors at local level
A new QUT-led study that maps health statistics in Australia highlights the disparities in small…
Mathematics supporting fresh theoretical approach in oncology
Mathematical approaches are gaining traction in modern oncology as they provide fresh knowledge about the evolution of cancer and new opportunities…
Melanoma trial offers hope for beloved stock and station agent
In January 2021, John Robson was celebrating his 60th birthday. Looking at the friendly faces…
AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients
- Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients
- Research uncovers how to target ‘sleeping’ breast cancer cells and prevent relapse
- Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer
Adding smoking cessation to lung cancer screening can reduce mortality by 14%
Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.